CAJ | 학술논문

引进国产膜肺在小儿先天性心脏病直视手术体外循环转流中应用技术。方法：将膜肺应用技术用于42例患儿。结果：42例患儿全部获得成功。体外转流中予充量小，气体交换良好，血气正常。术后无肺(PumpLung)等组织器官的并发症。提示：该技术提高了小儿，特别是婴幼儿先天性心脏病直视手术成活率，对减轻病人经济负担也有着重要作用。
인진국산막폐재소인선천성심장병직시수술체외순배전류중응용기술。방법：장막폐응용기술용우42례환인。결과：42례환인전부획득성공。체외전류중여충량소，기체교환량호，혈기정상。술후무폐(PumpLung)등조직기관적병발증。제시：해기술제고료소인，특별시영유인선천성심장병직시수술성활솔，대감경병인경제부담야유착중요작용。
To assess the value of a China-made membrane oxygenator (MO) in cardiopulmonary bypass during the operation of children′s congenital heart disease (CHD). Method: The MO was employed in the cardiopulmonary bypass in 42 children with CHD. Results: During the period of cardiopulmonary bypass, the pre-sufficiency was fewer, gas exchange was better, the data of blood gas analysis was normal and the postopera tive complications of pulmonary (pump lung) or other organs had not been found. Conclusions: The China-made MO could increase the survival rate of the children with CHD while undergoing the operation and decrease the operative expenses.